Clinical trial
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Study to Evaluate the Efficacy and Safety of TF0023 Spray Versus Placebo in Functional Improvement of Patients With Ischemic Strokes
NCT02785120 is registered in ClinicalTrials.gov with Techfields Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Study to Evaluate the Efficacy and Safety of TF0023 Spray Versus Placebo in Functional Improvement of Patients With Ischemic Strokes
- Lead sponsor
- Techfields Inc
- Phase
- Phase 2
- Overall status
- Suspended
- Start date
- March 1, 2017
- Completion date
- December 31, 2024
- Enrollment
- 225 (estimated)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.